glutamic acid has been researched along with Abnormal Movements in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Bonizzoni, E; Cattaneo, C; Jost, WH | 1 |
| Hatta, D; Hori, Y; Iwata, N; Kurotaki, N; Shirotani, K | 1 |
| Kalita, J; Kumar, S; Kumar, V; Misra, UK | 1 |
| Hao, J; Jiang, K; Ma, B; Wu, M; Zhang, X | 1 |
| Chen, WF; Ho, JT; Huang, SY; Jean, YH; Lin, CS; Su, TM; Sung, CS; Wang, HC; Wen, ZH | 1 |
| Asanuma, K; Chida, S; Davies, EM; Eguchi, S; Hirai, H; Horie, Y; Itoh, R; Kofuji, S; Mitchell, C; Miura, K; Momiyama, T; Murakami, H; Sasaki, J; Sasaki, T; Suzuki, A; Takasuga, S; Takayama, K; Takenawa, T; Tsuya, Y; Yamazaki, M | 1 |
| Downes, GB; Hall, VL; McKeown, KA; Moreno, R; Ribera, AB | 1 |
| Antonelli, T; Bartoszyk, GD; Ferraro, L; Fuxe, K; Seyfried, CA; Tanganelli, S; Tomasini, MC | 1 |
| Baunez, C; Bernardi, G; Calabresi, P; Centonze, D; De Chiara, V; Gubellini, P; Picconi, B; Prosperetti, C; Rossi, S; Tscherter, A | 1 |
| Boulet, S; Carcenac, C; Feuerstein, C; Lacombe, E; Poupard, A; Savasta, M; Sgambato-Faure, V | 1 |
| Danish, SF; Moyer, JT | 1 |
1 trial(s) available for glutamic acid and Abnormal Movements
| Article | Year |
|---|---|
Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson's Disease Patients.
Topics: Activities of Daily Living; Aged; Alanine; Antiparkinson Agents; Benzylamines; Double-Blind Method; Drug Therapy, Combination; Dyskinesias; Female; Glutamic Acid; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Outcome Assessment, Health Care; Parkinson Disease; Quality of Life; Severity of Illness Index | 2020 |
10 other study(ies) available for glutamic acid and Abnormal Movements
| Article | Year |
|---|---|
Activity-dependent cleavage of dyskinesia-related proline-rich transmembrane protein 2 (PRRT2) by calpain in mouse primary cortical neurons.
Topics: Amino Acid Sequence; Animals; Calpain; Cells, Cultured; Cerebral Cortex; Dyskinesias; Glutamic Acid; Male; Membrane Potentials; Membrane Proteins; Mice; Nerve Tissue Proteins; Neurons; Plasmids | 2020 |
Movement Disorder in Wilson Disease: Correlation with MRI and Biomarkers of Cell Injury.
Topics: Adolescent; Adult; Age of Onset; Biomarkers; Child; Cytokines; Disease Progression; Dyskinesias; Female; Glutamic Acid; Glutathione; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Male; Malondialdehyde; Movement Disorders; Neuroimaging; Oxidative Stress; Severity of Illness Index; Thiobarbituric Acid Reactive Substances; Young Adult | 2021 |
"Glu/GABA-Gln" metabolic loop abnormalities in iminodipropionitrile (IDPN)-induced dyskinetic syndrome.
Topics: Animals; Dyskinesias; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Male; Rats; Rats, Wistar | 2021 |
Suppressive effects of intrathecal granulocyte colony-stimulating factor on excessive release of excitatory amino acids in the spinal cerebrospinal fluid of rats with cord ischemia: role of glutamate transporters.
Topics: Animals; Aspartic Acid; Disease Models, Animal; Dyskinesias; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Excitatory Amino Acid Transporter 3; Excitatory Amino Acids; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Granulocyte Colony-Stimulating Factor; Injections, Spinal; Male; Nerve Fibers, Unmyelinated; Neuroprotective Agents; Random Allocation; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Ischemia | 2010 |
The PtdIns(3,4)P(2) phosphatase INPP4A is a suppressor of excitotoxic neuronal death.
Topics: Animals; Cell Death; Cell Survival; Cells, Cultured; Down-Regulation; Dyskinesias; Glutamic Acid; Humans; Mice; Mice, Inbred C57BL; Neostriatum; Neurodegenerative Diseases; Neurons; Phosphoric Monoester Hydrolases; Receptors, N-Methyl-D-Aspartate; Survival Rate; Synapses; Weight Loss | 2010 |
Disruption of Eaat2b, a glutamate transporter, results in abnormal motor behaviors in developing zebrafish.
Topics: Animals; Chromosome Mapping; Cloning, Molecular; DNA, Complementary; Dyskinesias; Electrophysiology; Excitatory Amino Acid Transporter 2; Gene Expression Regulation, Developmental; Glutamic Acid; In Situ Hybridization; Larva; Morpholinos; Mutation; Neuroglia; Neurons; Physical Stimulation; Swimming; Video Recording; Zebrafish | 2012 |
Effects of sarizotan on the corticostriatal glutamate pathways.
Topics: Animals; Antiparkinson Agents; Down-Regulation; Dyskinesias; Extracellular Fluid; Glutamic Acid; Male; Microdialysis; Motor Cortex; Neostriatum; Neural Inhibition; Neural Pathways; Organic Chemicals; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Synaptic Transmission | 2005 |
Deficits of glutamate transmission in the striatum of experimental hemiballism.
Topics: Anesthetics, Local; Animals; Corpus Striatum; Disease Models, Animal; Dopamine Antagonists; Dyskinesias; Electric Stimulation; Excitatory Postsynaptic Potentials; Glutamic Acid; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Sulpiride; Synaptic Transmission; Tetrodotoxin; Triazines; Triazoles | 2006 |
Subthalamic stimulation-induced forelimb dyskinesias are linked to an increase in glutamate levels in the substantia nigra pars reticulata.
Topics: Animals; Deep Brain Stimulation; Dyskinesias; Extracellular Fluid; Forelimb; Glutamic Acid; Male; Rats; Rats, Sprague-Dawley; Substantia Nigra; Subthalamic Nucleus | 2006 |
Stimulation-induced dyskinesias inform basal ganglia models and the mechanisms of deep brain stimulation.
Topics: Animals; Basal Ganglia; Deep Brain Stimulation; Dyskinesias; Glutamic Acid; Humans; Models, Neurological; Parkinson Disease; Substantia Nigra | 2007 |